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Abstract: Sudden unexpected death in epilepsy (SUDEP) is the major cause of death in those patients
suffering from refractory epilepsy (RE), with a 24-fold higher risk relative to the normal population.
SUDEP risk increases with seizure frequency and/or seizure-duration as in RE and Status
Epilepticus (SE). P-glycoprotein (P-gp), the product of the multidrug resistant ABCB1-MDR-1 gene,
is a detoxifying pump that extrudes drugs out of the cells and can confer pharmacoresistance to
the expressing cells. Neurons and cardiomyocytes normally do not express P-gp, however, it is
overexpressed in the brain of patients or in experimental models of RE and SE. P-gp was also detected
after brain or cardiac hypoxia. We have previously demonstrated that repetitive pentylenetetrazole
(PTZ)-induced seizures increase P-gp expression in the brain, which is associated with membrane
depolarization in the hippocampus, and in the heart, which is associated with fatal SE. SE can
produce hypoxic-ischemic altered cardiac rhythm (HIACR) and severe arrhythmias, and both are
related with SUDEP. Here, we investigate whether SE induces the expression of hypoxia-inducible
transcription factor (HIF)-1α and P-gp in cardiomyocytes, which is associated with altered heart
rhythm, and if these changes are related with the spontaneous death rate. SE was induced in Wistar
rats once a week for 3 weeks, by lithium-pilocarpine-paradigm. Electrocardiograms, HIF-1α, and P-gp
expression in cardiomyocytes, were evaluated in basal conditions and 72 h after SE. All spontaneous
deaths occurred 48 h after each SE was registered. We observed that repeated SE induced HIF-1α
and P-gp expression in cardiomyocytes, electrocardiographic (ECG) changes, and a high rate of
spontaneous death. Our results suggest that the highly accumulated burden of convulsive stress
results in a hypoxic heart insult, where P-gp expression may play a depolarizing role in cardiomyocyte
membranes and in the development of the ECG changes, such as QT interval prolongation, that could
be related with SUDEP. We postulate that this mechanism could explain, in part, the higher SUDEP
risk in patients with RE or SE.
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1. Introduction
Patients with Refractory epilepsy (RE) or Status Epilepticus (SE) can develop a wide spectrum
of cardiovascular events after severe convulsive seizures. These cardiac alterations include several
electrocardiography abnormalities with malignant arrhythmias, asystole, infarct, or even sudden
unexpected death in epilepsy (SUDEP), which is one of the most frequent causes of death among
these RE patients [1–3]. SUDEP has been defined as a type of death related with epilepsy in which
post-mortem anatomical and histological examination cannot disclose a clear cause of death [4,5].
Several conditions were described as risk factors for SUDEP, among which we can mention the
high frequency of generalized seizures without control, mainly in patients aged between 20 and
40 years, or non-compliance with the specific medications that leads to a lack of seizure control.
Interestingly, these situations can be observed in patients with RE receiving polytherapy where one of
the pharmacoresistant mechanisms is likely related to high P-glycoprotein (P-gp) brain expression [6–8].
In this regard, higher risk factors of SUDEP, such as the high frequency of generalized tonic-clonic
seizures (GTCS) and nocturnal seizures or a long history (more than 15 years) of seizures, have been
observed mainly in patients with a pharmacoresistant phenotype. So, when the seizure frequency
increases, the risk of SUDEP also increases [9], and this occurs particularly in patients after SE or severe
RE under polytherapy.
Previously, we described that daily induced-seizures with pentylenetetrazole (PTZ) increase
P-gp expression in the hippocampus, and it is related to increasing membrane depolarization.
This membrane depolarization cannot be reverted by phenytoin (PHT), but it was reverted when
nimodipine, a calcium channel and P-gp blocker, was added [10]. Accumulated SE episodes in these
animals lead to increased P-gp expression in the brain and heart, and ended with a fatal SE episode
in all rats [11]. Taking into account that a progressive depolarization of the plasma membranes
may affect myocardial function, we hypothesized that a fatal acute heart rhythm alteration could be
the consequence of a severe hypoxic stress produced by the SE, where overexpressed cardiac P-gp
plays the mentioned depolarizing role. Furthermore, experimental studies with animal models have
described autonomic dysregulation with altered cardiac repolarization during and between seizures
that could be the cause of SUDEP. These studies suggest that a harmful brain-heart connection could
start from severe convulsive stress, inducing an acute heart deficiency and ending with a fatal cardiac
arrhythmia [12–15].
Clinical and experimental studies have widely demonstrated that brain hypoxia-ischemia can
induce seizures or epilepsy [16–20]. However, whether repetitive episodes of severe seizures as well as
SE could induce chronic brain or systemic hypoxia-ischemia have been poorly investigated [21,22].
In this regard, one very complete experimental study confirmed the brain-heart connection in a model
of SE induced by kainate. In this study, animals developed a cardiomyopathy, characterized by
heart dysfunction with immediate elevation in plasma of noradrenaline, decreased ejection fraction,
QT prolongation, and histological changes. Furthermore, this dilated cardiomyopathy, including
cardiomyocyte vacuolization, apoptotic cells, cardiac fibrosis, and macrophages infiltration, was
evident within 48 h of seizure induction and remained present for up to 28 days after of SE induced by
kainate [23]. However, in this study, the role of hypoxia-inducible factor 1α (HIF-1α) and P-gp were
not investigated.
HIF-1α is the master transcriptional regulator of cellular and developmental response to hypoxia
in all tissues. Consequently, oxygen deprivation in the brain and heart induces stabilization and
nuclear translocation of HIF-1α and binding to the HRE-responsive genes that become upregulated.
Two examples of the HRE-responsive genes are the erythropoietin receptor and P-gp (ABCB1/MDR-1)
gene [24–28]. Based on the previously mentioned brain-heart connection, we speculate that severe
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and repetitive convulsive episodes or SE could generate a hypoxic-ischemic altered cardiac rhythm
(HIACR), which should induce a concomitant heart expression of HIF-1α and P-gp.
One of the best characterized experimental models of SE in rats is produced by intraperitoneal
(i.p.) administration of Li-Pilocarpine. This treatment induces SE followed by a silent period (~30 days
post-SE), after which the spontaneous seizures are established. Furthermore, in our laboratory, it has
been recently demonstrated that SE induced by Li-Pilocarpine also induces a parallel HIF-1α and P-gp
expression in the brain [29]. This SE model, in turn, resembles the alterations that occur in patients
with temporal lobe epilepsies [30], characterized by their pharmacoresistant phenotype and high
hippocampal expression of P-gp [31].
Based on these observations, we aimed to verify whether the model of Li-Pilocarpine-induced
SE produces a cardiac hypoxic condition with high expression of HIF-1α and P-gp in cardiomyocytes
associated with electrocardiographic (ECG) alterations, and whether these findings are related to an
increased spontaneous death rate.
2. Results
2.1. SE Strength Induces Heart Rate Variation
SE was induced by the Li-pilocarpine paradigm and was adjusted at 15, 30, 45, 60, 75, or 90 min of
duration with diazepam, and weight loss was observed after each SE in all rats. To know the strength
of the SE, we created the “SE-strength index”, which related the SE duration (in minutes) with post-SE
weight loss, and a positive correlation between the post-SE weight loss and the SE duration was found
(Figure 1A). The SE-strength index was calculated with a linear regression of R2 = 0.763.
After a recovery period, heart rate was evaluated with a standard ECG. A high inverse linear
correlation between heart rate and the SE-strength index (R2 = 0.9207) was observed, suggesting that
the heart rate reduction was increased according with SE severity (Figure 1B).
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2.2. ECG Changes after Single SE 
First, we measured the heart electrical function after the induction of only one SE episode. In the 
SE-group a decreased heart rate was observed. Additionally, QT time of the SE-group was also 
elongated by 15–20%, while PR interval and QRS amplitude post-SE remained unchanged. Because 
the QT time depends on the heart rate, we also analyzed the QT time with the normalized correction 
of Bazett´s formula (QTc), which indicated that after SE, QTc was increased independently of the 
heart rate (Table 1, Figure 2). 
  
Figure 1. Strength of single Status Epilepticus (SE). (A) SE strength index. A linear correlation between
SE time and lost weight 3 days after SE was observed. Note that the survival of the rats decreased with
longer SE time. (B) Inverse correlation between SE strength index and heart rate variation is observed.
The correlation’s coefficient (R2) and the confidence interval (dashed line) are showed in both graphics.
2.2. ECG Changes after Single SE
First, we measured the heart electrical function after the induction of only one SE episode. In the
SE-group a decreased heart rate was observed. Additionally, QT time of the SE-group was also
elongated by 15–20%, while PR interval and QRS amplitude post-SE remained unchanged. Because the
QT time depends on the heart rate, we also analyzed the QT time with the normalized correction of
Bazett´s formula (QTc), which indicated that after SE, QTc was increased independently of the heart
rate (Table 1, Figure 2).
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Table 1. Electrocardiograph (ECG) after one SE. Table shows the most common parameters of an ECG
to control group (No SE) and convulsive group (SE). QTc parameter represents QT time corrected by
the Bazzet normalized equation. The values are listed as mean ± standard error and differences were
analyzed by Student t-test with p < 0.05 (*).
ECG No SE (n = 3) SE (n = 7)
Heart rate (beats/m) 321 ± 8.64 271 ± 9.03 *
RR interval (ms) 187 ± 5.05 223 ± 8.32 *
PR interval (ms) 50.5 ± 0.29 49 ± 1.22
QRS amplitude (mV) 27.3 ± 2.19 27.1 ± 1.03
QT (ms) 72 ± 0.50 85.3 ± 3.74 *
QTc (ms) 71.9 ± 1.60 85.5 ± 3.68 *
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3. Discussion
Our study documents that weekly induction of SE for several weeks constitutes a model of
convulsive stress with persistent ECG changes, characterized by prolongation of the QT interval and a
high spontaneous death rate. The mechanism by which severe and repetitive convulsive stress could
result in potentially fatal cardiac dysfunction is not fully understood. We speculate that prolonged
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generalized tonic-clonic seizures reaching the status epilepticus level should be assumed to be a severe
hypoxic systemic stress.
A complex bidirectional interaction between the brain and heart exists, and in this context,
prolonged or repetitive seizures could induce the activation of several hypoxia responsive genes in
the heart. The most important modulator of these genes is the hypoxia-inducible factor-1α (HIF-1α),
a transcription factor that is rapidly induced under hypoxia, and almost instantaneously degraded by
proteasome when oxygen supply is normalized [28].
Because of this particular ability, the moderated number of cardiomyocytes expressing HIF-1α
found at 72 h after the SE episode could be the consequence of a residual expression of HIF-1α
activated during SE, but stabilized according to the remaining heart rate reduction. Interestingly,
it is important to remark that HIF-1α evaluation was developed in rats during a period away from
the acute convulsive episode. At this time, persistence of positive labelling for HIF-1α suggested
that persistent bradycardia could be the cause of a chronic hypoxic injury affecting all organs and
tissues (including brain and heart). So, the observed nuclear location of HIF-1α in cardiomyocytes is
clear evidence that the heart was affected by hypoxia-ischemia during the SE episode and remained
injured by the persistent heart rate reduction. In this context, a new event of excitotoxicity, perhaps not
clinically evident as nocturnal seizures, could trigger a sudden death. In this regard, all rats were also
found dead during a period away from the acute convulsive episode.
All in all, repetitive convulsive stress such as SE, could be a systemic acute hypoxic insult strong
enough to induce a hypoxic-ischemic altered cardiac rhythm (HIACR) [3]. Because the ABCB1/MDR1
gene encoding the multidrug transporter P-glycoprotein (P-gp) is an HRE (HIF-1α) responsive
gene [32], persistent HIF-1α expression in cardiomyocytes from convulsive rats (Figure 3) could
explain why P-gp was robustly expressed in these cells (Figure 4).
In a wide spectrum of experimental models of acute and chronic hypoxia in vivo, brain and
heart expression of P-gp was previously demonstrated by us. In some of these studies, P-gp
was simultaneously expressed with HIF-1α and another HIF-1α inducible gene as erythropoietin
receptors (EPO-R) [25,33–35], where pharmacological nasal administration of human recombinant
EPO protected the ischemic brain area [24]. Two other experimental studies of chronic and acute
heart hypoxia-ischemia, developed in pigs and sheep, respectively, have demonstrated a significant
loss of 99mTc-2-Methoxyisobutylisonitrile (99mTc-SESTAMIBI) heart retention in the affected ischemic
heart regions with a concomitant high expression of P-gp and the associated heart stunning [36,37].
These results could be the consequence of the active expression of P-gp, which not only plays a
role in the radiotracer extrusion, but could also be directly involved in the intrinsic mechanism of
cardiomyocytes membrane depolarization, as previously described in other cells [38–41]. Furthermore,
in patients with dilated cardiomyopathy, an increased cardiac washout of 99mTc-SESTAMIBI has been
described, suggesting that this altered single-photon emission computed tomography (SPECT) study
may predict mitochondrial dysfunction and impairment of myocardial contractile and relaxation
functions during stress [42].
All this evidence reinforces our previous report showing that after repetitive seizures, the induced
P-gp brain expression can contribute to cell membrane depolarization of the hippocampus
and neocortex. In rats with repetitive seizures produced by daily doses of pentylenetetrazole (PTZ),
a progressive phenytoin (PHT) resistant epileptic phenotype was observed, where an increased brain
expression of P-gp was documented, and membranes were progressively depolarized. The recovery
of a PHT-sensitive phenotype, and normalized membrane potential, were restored when PHT was
administered together with nimodipine, a calcium channel blocker that also inhibits P-gp activity [10].
In this regard, we should point out that pioneer studies have demonstrated that P-gp can modify
the resting membrane potential, producing depolarization with values from −70 to −10 mV [43,44].
In this regard, in a more recent preliminary experiment in rats developed under similar conditions as
presented here, we can observe an important reduction of 99mTc-SESTAMIBI heart retention 72 h after
pilocarpine-induced SE [45]. This experiment was not developed to follow-up on heart alterations by
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dilated cardiomyopathy previously described after kainate-induced SE [23], however, our results could
predict this alteration as mentioned above [42]. This preliminary experiment should be confirmed
by more SPECT-stdies; its results are a clear demonstration that P-gp expressed in cardiomyocytes
is active. In a purely speculative scenario, we believe that a range or zone of values showing “low
99mTc-SESTAMIBI heart retention” could reveal the hypoxic-induced membrane depolarization in
cardiomyocytes related with heart dysfunction after SE. This last condition could explain a persistent
HIACR secondary to the convulsive stress with a later spontaneous sudden death as the SUDEP
observed in patients underlying SE or severe refractory epilepsies.
One intriguing characteristic of the current study is the high rate of spontaneous death, observed
more than 48 h after each SE episode, which increased when the convulsive burden by repetitive
induced SE accumulated. This particular feature resembles our previously mentioned studies where
repetitive seizures induced in two independent experiments using two different seizure-inducers
ended with fatal status epilepticus, and in both cases a progressive increase of P-gp expression in brain
and heart was documented [8,11].
It is wildly accepted that acute myocardial ischemia results in greater membrane depolarization
(less negative resting potential), which alters the cellular electrophysiology and the conduction of
action potentials within the heart; these changes are reflected in the ECG pattern [46,47]. Within these
alterations, the QT interval that represents the overall time required for initiation and completion
of ventricular depolarization and repolarization can be longer, indicating membrane depolarization
that is clinically reflected as bradycardia. Interestingly, in our study, the heart rate reduction got
worse with successive SE and was associated with a higher spontaneous death ratio. Additionally,
the heart rate reduction progressed with successive SE and was associated with a higher spontaneous
death ratio. We postulate that the prolongation of the QT interval leads to spontaneous death, related
to the continuous depolarizing function of P-gp in cardiomyocytes aggravated after each SE (Figure 4).
To date, the role of P-gp on membrane potential of hypoxic-ischemic cardiomyocytes has
not been described. Is P-gp contributing to membrane depolarizations of cardiomyocytes after
seizure-related severe hypoxia, as we previously described in hippocampus and neocortex? In the
clinical setting, the most common cardiac response observed in both adults and children after complex
partial crisis, as well as generalized tonic–clonic seizures, is increased heart rate in nearly 90% of the
cases [48], while bradycardia or asystole related to seizures are very rare [47]. However, some studies
have demonstrated that seizure-related bradycardia could be an important feature in patients with
refractory epilepsy, and this heart failure could be associated with a higher risk of SUDEP [49–52].
It was reported that 40% of patients with refractory focal epilepsy had seizure-related ST-segment
depression, suggesting that cardiac ischemia might occur during seizures [21]. However, in a
complementary study from the same group of researchers, the patients with complex partial
or generalized tonic–clonic seizures did not have elevated cardiac troponin levels after these
crises [53]. Both reports suggest that heart ischemic episodes observed after seizures could be
related to dysfunctional electrical properties more than with damaged cardiac tissue. Furthermore,
a meta-analysis evaluating the heart rate variability (HRV) supports the hypothesis that autonomic
cardiac dysfunction might play a role in SUDEP etiology, mainly in cases with low heart rate variability
and bradycardia, or reduced vagal activity. This study also highlights that HRV can be a predictor of
cardiovascular morbidity and mortality in patients with previous heart conditions [54]. Because the
HRV index can be easily determined, it was recently suggested to be a useful predictive tool for the
indication of vagal nerve stimulation as an alternative treatment of refractory epilepsy, in addition,
it showed protective effects on the heart [55,56]. According to these descriptions, in our experiment,
the observed heart rate reduction was not only sustained 24–48 h after each SE episode and associated
with an increase of QT interval, but also was progressively more severe when the seizure load was
increased, and it was associated with an increase in the death rate.
Our results, appear to be in accordance with a very recent communication that demonstrates a
simultaneous P-gp overexpression in brain and peripheral tissues after ischemic stroke in rats [57].
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Here, we are reporting for the first time that SE induced a sustained HIF-1α nuclear translocation
driving a high P-gp expression in cardiomyocytes, which can contribute to their membrane
depolarization, developing the ECG alterations with persistent a severe heart rate and prolonged
QT interval. These conditions create a favorable scenario where new convulsive stress has a high
possibility of inducing a sudden fatal heart failure, produced outside of the acute convulsive episode
as observed in our study, and we assumed as a SUDEP experimental model.
4. Materials and Methods
4.1. Ethics Statement
All procedures involving animals and their care were conducted in accordance with our
institutional guidelines, which comply with the National Institutes of Health (NIH) guidelines for
the Care and Use of Laboratory Animals and the principles presented in the Guidelines for the Use
of Animals in Neuroscience Research by the Society for Neuroscience, and were approved by the
institutional committee for the care and use of experimental animals (CICUAL) of the School of
Pharmacy and Biochemistry, University of Buenos Aires. All efforts were made to minimize animal
suffering and to reduce the number of animal used.
4.2. Status Epilepticus Protocol
Status Epilepticus was induced in Wistar rats of 300 g using the Lithium-Pilocarpine paradigm [29],
plus Diazepam (DZP) to stop the crisis. Briefly, SE was induced by i.p. administration of lithium
(127 mg/kg), and 20 h later, pilocarpine (30 mg/kg). Severity of seizures was evaluated according
to the Racine scale [58], and the rats were considered to have suffered SE when they remained for
more than 5 min with myoclonic and/or tonic-clonic generalized seizures (stages 4 and 5 of said
scale); DZP (20 mg/kg, i.p.) was given at different times after SE according to the experiment.
All animals were monitored for the recovery period (24 h after each SE) in which they received 0.5 mL
of physiological solution (i.p) every 6 h to maintain hydration. The control non-convulsive group was
injected with a Lithium-saline solution. Once SE per week was induced, a single SE or multiple SE
experimental schemes were used.
4.3. Experimental Scheme
Two different schemes were used. First, a single SE was induced and 24 h after the recovery
period their heart function was evaluated and compared to that of a control group. Second, one SE
per week was induced over three weeks. The basal ECG was studied in all animals previously to
the induction of the first SE. After 24 h of each recovery period we evaluated the heart function, and
then we analyzed the evolution compared to the basal ECG. We recorded sudden death after each SE,
but excluded dead rats during SE or recovery period. In both experimental schemes, rats were allowed
to freely convulse in room air.
4.4. Electrocardiographic and Heart Rate Evaluation
Both control and convulsive rats were anesthetized with a mixture of Ketamine (35 mg/kg)
and xylazine (5 mg/kg) administered intraperitoneally, as mentioned, to achieve a mild anesthesia.
A standard ECG with needle-shaped electrodes placed subcutaneously in the four limbs was performed.
After 5–10 min of stabilization period, a baseline ECG recording was taken. Simultaneously, the heart
rate was evaluated from the length of the cardiac cycle (RR interval duration), the duration of the
PR interval from the start of the P wave to the start of the QRS complex, and the duration of the
QT interval from the start of the QRS to the end of the T wave. All variables were measured in five
cycles in the DII derivative, and the arithmetic mean of each one was calculated. The measured QT
interval values were corrected using the (QTc = QT/(RR) 1/2) and the normalized Bazzet equation
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(QTcn = QT/(RR/f) 1/2), where f is the factor of normalization that arises from values of the basal RR
intervals [59].
4.5. Immunohistochemistry
After deep anesthesia with ketamine/xylazine (90/10 mg/kg), animals were sacrificed by
intracardiac perfusion with 4% paraformaldehyde in phosphate buffer as previously described [29].
Frozen hearts were cut into 14-micron sections and mounted on slides. Subsequently, the sections
were dehydrated to perform the inhibition of endogenous peroxidase with H2O2 (0.5% v/v in
methanol) for 30 min at room temperature; then rehydrated and permeabilized with 1% Triton X-100
in buffer phosphate saline (PBS) for 30 min. Nonspecific sites were blocked with 3% equine normal
serum in PBS for 30 min, and incubation with anti-P-gp (dilution: 1/500; EPR10364-57 Abcam Inc.,
Cambridge, MA, USA) was performed for 48 h at 4 ◦C. Subsequently, incubation with a biotinylated
secondary antibody (dilution 1/800; B7389 Sigma, St. Louis, MO, USA) was performed for 3 h at
room temperature. Immunoreactivity was revealed with diaminobenzidine/nickel until coloration
was observed and mounted with DPX (Distrene-Plasticizer- Xylene) mounting medium. Slides were
also treated with monoclonal antibody anti-HIF-1α (dilution: 1/500 NB-100-131 NovusBio, Littleton,
CO, USA) and revealed by immunofluorescence using a labelled Alexa488 donkey anti-mouse (Jackson
ImmunoResearch Laboratories, Inc., West Grove, PA, USA).
5. Conclusions
We postulate that SUDEP can be induced by SE or highly frequent severe generalized seizures
themselves, and it must be assumed to be a severe hypoxic event. SUDEP is a process related to the
cumulative burden of convulsive stress that progressively will install the pharmacoresistant phenotype.
Another consequence of an induced seizure is the simultaneous high expression of P-gp in the brain
and heart. Under these considerations, our results suggest that increased P-gp expression in the
heart contributes to the membrane depolarization of cardiomyocytes resulting in an acute and fatal
alteration of heart rhythm. These experimental results could help to explain, in part, the particularly
high frequency of SUDEP observed in RE patients, in whom P-gp can be over expressed. In these
patients with repetitive generalized-seizure stress, a high cumulative burden of heart hypoxia-ischemic
condition can induce heart P-gp expression, leading to an epileptic-related fatal HIACR, as a
mechanism of SUDEP.
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